IHM
VYGR icon

Iguana Healthcare Management’s Voyager Therapeutics VYGR Stock Holding History

Iguana Healthcare Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.31M Buy
70,000
+20,000
+40% +$432K 0.87% 42
2017
Q4 		$830K Buy
50,000
+25,000
+100% +$429K 0.54% 52
2017
Q3 		$515K Buy
+25,000
New +$282K 0.28% 63

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Iguana Healthcare Management's VYGR Position: Q1 2018 in Review

Iguana Healthcare Management increased its Voyager Therapeutics (VYGR) stake by 40% in Q1 2018, buying an estimated $432K and bringing the position to 70,000 shares worth $1.31M. The position accounts for 0.87% of the portfolio, ranked #42.

Iguana Healthcare Management first reported a position in VYGR in Q3 2017 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold VYGR as of Q1 2018.

  • Iguana Healthcare Management held 70,000 shares of Voyager Therapeutics worth $1.31M as of Q1 2018.
  • Iguana Healthcare Management bought 20,000 Voyager Therapeutics shares in Q1 2018, an estimated $432K.
  • Voyager Therapeutics made up 0.87% of Iguana Healthcare Management's portfolio in Q1 2018, its #42 holding.
  • Iguana Healthcare Management first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 3 quarters since.
  • 108 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.